VBI Vaccines Appoints Linda Bain to Board of Directors
CAMBRIDGE, Mass., July 07, 2021–(Small business WIRE)–VBI Vaccines Inc. (Nasdaq: VBIV) (VBI), a biopharmaceutical organization driven by immunology in the pursuit of potent avoidance and therapy of disease, nowadays announced that Linda Bain, Chief Money Officer of Codiak BioSciences, Inc., has joined its Board of Administrators. Ms. Bain is an accomplished economical and business government with much more than two a long time of finance, technique, and board experience in the two tiny and substantial public organizations in the biotechnology and pharmaceutical marketplace.
“Linda has intensive encounter driving the company and financial system of biotech firms and we are delighted to be equipped to welcome her to our Board,” said Jeff Baxter, VBI’s President and CEO. “Linda’s confirmed monitor report of translating scientific achievements into organizational and money growth, and her deep knowledge of the life sciences business and fiscal management will make her an instrumental director as VBI prepares for the corporate milestones and evolution forward.”
“I am excited to be joining VBI’s Board at this kind of a transformational time,” said Ms. Bain. “VBI has an extraordinary pipeline and management team, and I search forward to working with my fellow administrators to support guidebook VBI’s strategy as the team functions to advance various meaningful clinical candidates and to get ready for the launch of the company’s 3-antigen hepatitis B vaccine applicant.”
As CFO of Codiak BioSciences, Inc., Ms. Bain led the organization as a result of its original general public presenting (IPO) and initial adhere to-on financing, creating on the results of earlier-stage financing rounds. Ms. Bain plays a guide job in setting up Codiak’s strategic route and she crafted and qualified prospects finance and company functions, such as investor relations and company communications, finance, accounting, amenities and details technology. Prior to joining Codiak, Ms. Bain was CFO at Adverum Biotechnologies, Inc. (previously Avalanche Biotechnologies, Inc.) and Vice President, Finance, Company Functions, and Treasurer at bluebird bio, Inc., wherever she performed an instrumental role in the IPO for each and every firm. Ms. Bain has also held leadership roles at Genzyme Company, together with Vice President, Finance, World wide Production and Operations, and Vice President, Finance of Genzyme Genetics, in addition to senior roles at Fidelity Investments, AstraZeneca Pharmaceuticals, and as an auditor at Deloitte & Touche.
Ms. Bain also serves on the Board of Administrators for Autolus Therapeutics plc and Arvinas, Inc. She gained a Bachelor of Science in Accounting and Company Administration and an Honors degree in Accounting and Company Administration from the University of the Absolutely free Point out, found in South Africa.
About VBI Vaccines Inc.
VBI Vaccines Inc. (“VBI”) is a biopharmaceutical business driven by immunology in the pursuit of powerful prevention and procedure of sickness. By its innovative approach to virus-like particles (“VLPs”), such as a proprietary enveloped VLP (“eVLP”) platform know-how, VBI develops vaccine candidates that mimic the all-natural presentation of viruses, intended to elicit the innate energy of the human immune method. VBI is fully commited to concentrating on and overcoming major infectious ailments, like hepatitis B, coronaviruses, and cytomegalovirus (CMV), as well as intense cancers like glioblastoma (GBM). VBI is headquartered in Cambridge, Massachusetts, with investigation functions in Ottawa, Canada, and a investigate and production internet site in Rehovot, Israel.
Site House: http://www.vbivaccines.com/
Information and Resources: http://www.vbivaccines.com/news-and-means/
Traders: http://www.vbivaccines.com/buyers/
Cautionary Assertion on Ahead-on the lookout Information and facts
Particular statements in this push launch that are ahead-seeking and not statements of historical point are ahead-searching statements in the which means of the secure harbor provisions of the Non-public Securities Litigation Reform Act of 1995 and are forward-seeking info in just the indicating of Canadian securities guidelines (collectively, “forward-on the lookout statements”). The Organization cautions that these statements involve hazards and uncertainties that might materially impact the Company’s final results of functions. This kind of ahead-seeking statements are centered on the beliefs of administration as nicely as assumptions designed by and information and facts at this time out there to management. Real success could vary materially from these contemplated by the ahead-wanting statements as a outcome of sure aspects, including but not confined to, the impression of common economic, marketplace or political conditions in the United States or internationally the effect of the ongoing COVID-19 pandemic on our medical research, manufacturing, business enterprise approach, and the global financial system the skill to set up that opportunity goods are efficacious or harmless in preclinical or clinical trials the capacity to establish or retain collaborations on the enhancement of therapeutic candidates the potential to acquire correct or important governmental approvals to current market prospective goods the skill to obtain upcoming funding for developmental merchandise and functioning money and to attain such funding on commercially fair terms the Company’s capability to manufacture merchandise candidates on a professional scale or in collaborations with 3rd get-togethers changes in the size and character of opponents the means to keep vital executives and scientists and the ability to secure and enforce legal legal rights similar to the Company’s merchandise. A dialogue of these and other aspects, like threats and uncertainties with regard to the Company, is established forth in the Company’s filings with the SEC and the Canadian securities authorities, such as its Yearly Report on Form 10-K filed with the SEC on March 2, 2021, and filed with the Canadian protection authorities at sedar.com on March 2, 2021, as may be supplemented or amended by the Company’s Quarterly Experiences on Type 10-Q. Given these risks, uncertainties and aspects, you are cautioned not to area undue reliance on this sort of ahead-on the lookout statements, which are qualified in their entirety by this cautionary assertion. All such forward-wanting statements designed herein are based mostly on our current expectations and we undertake no responsibility or obligation to update or revise any forward-looking statements for any rationale, apart from as demanded by regulation.
Watch source version on businesswire.com: https://www.businesswire.com/information/property/20210707005162/en/
Contacts
VBI Get in touch with
Nicole Anderson
Director, Company Communications & IR
Cellular phone: (617) 830-3031 x124
Electronic mail: [email protected]
